P642-0675 Screening compound: 4-{4-[5-(4-methylpiperidine-1-carbonyl)-1,2,4-oxadiazol-3-yl]pyridin-2-yl}morpholine

P642-0675 Screening compound: 4-{4-[5-(4-methylpiperidine-1-carbonyl)-1,2,4-oxadiazol-3-yl]pyridin-2-yl}morpholine
P642-0675 Screening compound: 4-{4-[5-(4-methylpiperidine-1-carbonyl)-1,2,4-oxadiazol-3-yl]pyridin-2-yl}morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound P642-0675
4-{4-[5-(4-methylpiperidine-1-carbonyl)-1,2,4-oxadiazol-3-yl]pyridin-2-yl}morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P642-0675

Molecular Formula

C18H23N5O3 (C18 H23 N5 O3)

Compound Name

4-{4-[5-(4-methylpiperidine-1-carbonyl)-1,2,4-oxadiazol-3-yl]pyridin-2-yl}morpholine

IUPAC name

4-{4-[5-(4-methylpiperidine-1-carbonyl)-124-oxadiazol-3-yl]pyridin-2-yl}morpholine

SMILES

CC(CC1)CCN1C(c1nc(-c2cc(N3CCOCC3)ncc2)no1)=O

InChI

InChI=1S/C18H23N5O3/c1-13-3-6-23(7-4-13)18(24)17-20-16(21-26-17)14-2-5-19-15(12-14)22-8-10-25-11-9-22/h2,5,12-13H,3-4,6-11H2,1H3

InChI Key

OKBBIDPNIGSQST-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27608861

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

357.41

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.727

Distribution Coefficient, logD

2.726

Water Solubility, LogSw

-2.98

Polar Surface Area

68.436

Acid Dissociation Constant (pKa)

23.71

Base Dissociation Constant (pKb)

4.44

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

55.60

P642-0675 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P642-0675 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P642-0675?
Check Price and Availability of P642-0675, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P642-0675 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P642-0675
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P642-0675
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P642-0675 available by request